Recent progress in vaccines against fungal diseases

Related Experiment Video

Updated: May 22, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Antonio Cassone1, Arturo Casadevall

  • 1Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Current Opinion in Microbiology
|May 9, 2012
PubMed

Insights

Fungal infections pose a significant health threat, especially to immunocompromised individuals. New antifungal vaccines are showing promise in preclinical and early clinical trials to combat these challenging diseases.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Fungal diseases are a growing global health concern, particularly for immunocompromised individuals.
  • Current antifungal therapies have limited effectiveness, leading to treatment failures and high mortality rates.
  • There is a critical need for novel treatments and preventive strategies against fungal infections.

Purpose of the Study:

  • To highlight the urgent need for new antifungal interventions.
  • To review recent advancements in the development of antifungal vaccines.
  • To assess the potential of vaccines as preventive and therapeutic tools against fungal diseases.

Main Methods:

  • Review of recent scientific literature on antifungal vaccine development.
  • Analysis of preclinical data on vaccine immunogenicity and efficacy.
  • Examination of early-phase clinical trial results for antifungal vaccines.

Main Results:

  • Significant progress has been made in developing highly immunogenic and protective antifungal vaccine formulations.
  • Several promising vaccine candidates have emerged from preclinical research.
  • At least two vaccine candidates have advanced to Phase 1 clinical trials for candidiasis.

Conclusions:

  • Antifungal vaccines represent a major potential advancement in combating fungal diseases.
  • Recent research indicates a promising future for vaccine-based strategies against fungal infections.
  • Further clinical development is warranted to establish the safety and efficacy of these novel vaccines.

More Related Videos

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...